scorecardresearch
Add as a preferred source on Google
Saturday, January 24, 2026
TopicMolnupiravir

Topic: Molnupiravir

WHO adds Pfizer’s 2-drug antiviral Paxlovid to Covid recommendations for high-risk patients

WHO Guideline Development Group recommends oral drug Paxlovid for patients with non-severe Covid-19 who are at high risk of hospitalisation.

Panic stockpiling of Molnupiravir can result in similar harm seen last summer. Govt must regulate

ThePrint view on the most important issues, instantly.

Antiviral Molnupiravir not in govt Covid protocol, but ‘millions of doses’ distributed in a week

Pharma companies say doctors working in community settings have begun pre-ordering the drug, several manufacturers gearing up to meet demand.

Week since Molnupiravir was approved for Covid use, few doctors prescribing it, want to wait

Doctors say Molnupiravir may help keep people out of hospitals, but there are concerns about its ability to cause mutation as well as its prescribed dose.

Merck Covid pill raises new hope of reducing hospitalisation & death by up to 50%

Molnupiravir is an oral antiviral medicine meant to be taken by patients soon after symptoms manifest themselves, says Merck citing interim data

On Camera

Controversial dog-walker IAS Sanjeev Khirwar is back in Delhi. What happened to his wife?

In 2022, athletes claimed they were asked to wind up training early at Thyagraj Stadium so that the IAS couple could walk their dog. Then came the memes and public outrage.

IndiGo profit plunges 78% as Dec meltdown with 3k flight cancellations takes a toll

Net income for InterGlobe Aviation Ltd slipped 78 percent to Rs 5.5 billion for the three months ended Dec 31 compared with the year-ago period.

Rafale saga: 25 yrs of detours, deadlocks & political hesitation. Now IAF getting what it always wanted

Instead of buying more Mirages outright in early 2000s, the requirement was tweaked in favour of a medium-weight, multi-role fighter with Mirage-like performance. 

Pakistan se azaadi. Grow up India, stop giving it prime real estate in your psyche

Pakistan not only has zero chance of catching up with India in most areas, but will inevitably see the gap rising. Its leaders will offer its people the same snake oil in different bottles.